Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
The serotonin transporter gene promoter polymorphism (5-HTTLPR) has been repeatedly associated with antidepressant response in mood disorder patients, but findings are not consistent across studies. A meta-analysis was performed on 15 studies including data of 1435 subjects. We tested three phenotypes: remission rate, response rate and response rate within 4 weeks using the cochrane review manager. We observed a significant association of the s/s variant of 5-HTTLPR with remission rate (P<0.0001) and both s/s and s/l variants with response rate (P=0.0002). Response rate within 4 weeks was associated in both models (P=0.003-P<0.00001). This effect is quite robust to ethnic differences although a significant heterogeneity is present in Asian samples.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“L-alleles result in greater mRNA transcription and more active 5-HTT function (Parsey et al., 2006) and have been associated with a better treatment response to selective serotonin reuptake inhibitor (SSRI) antidepressants although discrepant findings exist (Serretti et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Serretti et al., 2007
Citations
Cites
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Hu, X.-Z., Lipsky, R. H., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B. D., Xu, K., Arnold, P. D., Richter, M. A., Kennedy, J. L., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503850 · Cited by 1,123
(1994) · PharmacoResources · doi:10.1007/bf03289581 · Cited by 974
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Meta-analysis of genetic association studies
Munafò, M. R., & Flint, J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.014 · Cited by 642
The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants
Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000698 · Cited by 633
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Perez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Cited by
Items 501–535 of 535
(2008) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2008.13.4.4
Genetik und Gen-Umwelt-Interaktionen bei psychischen Erkrankungen
Maier, W., Giegling, I., & Rujescu, D. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_5-1 · Cited by 1
Genetik und Gen-Umwelt-Interaktionen bei psychischen Erkrankungen
Maier, W., Giegling, I., & Rujescu, D. (2017) · Springer eBooks · doi:10.1007/978-3-642-45028-0_5-2 · Cited by 1
PSYCHOPHARMACOLOGICAL TARGETS IN PERSONALIZED PSYCHIATRY
Neamţu, M., Moşoiu, C., Ababei, D. C., Rusu, R.-N., & Bild, V. (2022) · Journal of Experimental and Molecular Biology · doi:10.47743/jemb-2021-60
Oakly, A. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013845
Pharmacogenomics in psychiatric diseases
Wali, A., Dar, M. A., Ali, A., Rasool, I., Tariq, L., Arafah, A. M., Rehman, M. U., Malla, B. A., & Wali, A. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15336-5.00002-6
Approches neurocomputationnelles de la prise de décision sociale
Philippe, R. (2021) · theses.fr (ABES) · doi:10.70675/61804b3fza366z4bb4z89e3z33fbdd3f17fe
Николаевич, П. К., Агибалова, Т. В., Buzik, O. Z., & Masyakin, A. V. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2403-09
Shokrnejad-Namin, T., Amini, E., Khakpai, F., & Zarrindast, M. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.05.003
“Additionally, given that l/l relative to s/s homozygotes indicate stronger SSRI functions in clinical (Serretti et al., 2007) and laboratory studies (Whale et al., 2000), citalopram treatment should induce stronger reductions in pain-correlated brain activity in l/l homozygotes.”
Chapter 2. Neurotransmitters, Receptors, and Transporters
Berg, K. A., Clarke, W. P., Daws, L. C., Frazer, A., Girotti, M., & Lodge, D. J. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as02
Jacobs, J. T., Maior, R. S., Waguespack, H. F., Campos-Rodríguez, C., Málková, L., & Forcelli, P. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06651-4 · Cited by 1
“Additionally, both clinical (Arias et al. 2003; Serretti et al. 2007; Yu et al. 2002; Zanardi et al. 2001) and preclinical (Christian et al. 2013; Guiard et al. 2012; Wilson et al. 2020) studies have suggested that 5-HT transporter (5-HTT) isoform can impact response to SSRIs and drugs that…”
Farmacogenômica e transtornos afetivos: origens, fundamentos e aplicabilidade clínica
Netto, V. D. M. (2012) · Debates em Psiquiatria · doi:10.25118/2763-9037.2012.v2.889
The Serotonin Hypothesis: An Umbrella Review of Depression Evidence
Ning, M., R, C. P. S., & Sumalatha, G. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr241202212221
“Some studies suggest that individuals with the L allele respond better to selective serotonin reuptake inhibitors (SSRIs) compared to those with the S allele (Serretti et al., 2007).”
Klanduchová, E. (2022) · Saudi Journal of Obesity · doi:10.4103/sjo.sjo_10_24
Гареева, А. Э., Borodina, L., Mikhailova, E. G., Pozdnyakov, S. A., & Тимербулатов, И. Ф. (2025) · Pharmacogenetics and Pharmacogenomics · doi:10.37489/2588-0527-2025-1-9-16
Quatela, I., & Sachs, B. D. (2025) · Veritas Villanova Research Journal · doi:10.61372/vvrj.v7i1.3150
“They found that the expression of certain alleles in the SERT can result in non-response, suppressed response, or delayed response of SSRIs (15).”
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583416
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583419
Ringleb, M., & Javelle, F. (2023) · OSF Preprints (OSF Preprints) · doi:10.17605/osf.io/guatx
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583413
Ellerbrock, I., Sandström, A., Tour, J., Fanton, S., Kadetoff, D., Schalling, M., Jensen, K. B., Sitnikov, R., & Kosek, E. (2021) · Figshare · doi:10.6084/m9.figshare.14583422
Joensuu, M. (2019) · UEF eRepo (University of Eastern Finland)
Li, L. (2022) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
The Genetic Mosaic of Depression: Linking Polymorphisms to Neuroplasticity and Stress Regulation
Bednářová, A., Szilassyová, E., Jarčušková, D., Múdry, D., & Kisková-Šimková, T. (2026) · Pharmaceuticals · doi:10.3390/ph19020336
Lisoway, A. J. (2025) · TSpace (University of Toronto)
Rubens, M. (2026) · Queensland University of Technology · doi:10.5204/thesis.eprints.263605
Molecular Aspects of Depressive Disorders
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_8
Individualized pharmacogenomics for depressive episodes: A narrative review
HADDAD, M., Dieckmann, L. H. J., Hoss, G. R. W., Mari, J. D. J., Young, A. H., & Juruena, M. F. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122261
Lee, S. W. Y., Kim, S. M., Lee, D., Hasanuzzaman, M., Park, D. W., Rahaman, M. I., Lee, S., Gu, Y., Kim, H. W., Park, W., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70597
FAISAL, D. M., Zakki, S. A., Rafiullah, R., & Farhat, K. (2026) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v76isuppl-8.14163
Pharmacogenetics and Pharmacogenomics in Psychiatry: Challenges and Opportunities
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8475-0
Tatham, E. L. (2014) · MacSphere (McMaster University) · doi:10.71548/8098
Sleep and Psychopathology: Quantitative and Molecular Genetic Research on Comorbidity
Barclay, N. L., & Gregory, A. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9509-3_5
Affective-related endophenotypes in serotonin transporter over-expressing mice
Dawson, N. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Genetik bei psychischen Erkrankungen
Maier, W., & Rujescu, D. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_5
Metadata
- Authors
- Serretti, A., Kato, M., De Ronchi, D., & Kinoshita, T.
- Affiliations
- University of Bologna (IT)
- Kansai Medical University (JP)
- Corresponding author
- Serretti, A
- Venue
- Molecular Psychiatry
- Published
- 2006-12-05
- Volume
- 12
- Issue
- 3
- Pages
- 247-257
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1982886582
- Cited by
- 529
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 44 · 2020: 10 · 2019: 18 · 2018: 22 · 2017: 23 · 2016: 28 · 2015: 29 · 2014: 23 · 2013: 38 · 2012: 39
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- 5-HTTLPR, serotonin transporter gene, promoter polymorphism, selective serotonin reuptake inhibitors, antidepressant response, depression, remission rate, genetic association, ethnic differences, Asian populations
- MeSH terms
- Adult, Aged, Depressive Disorder, Female, Humans, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, MEDLINE, Selective Serotonin Reuptake Inhibitors, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.